These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 201536)

  • 21. Characterization of a factor inducing differentiation of mouse myeloid leukemic cells purified from conditioned medium of mouse Ehrlich ascites tumor cells.
    Tomida M; Yamamoto-Yamaguchi Y; Hozumi M
    FEBS Lett; 1984 Dec; 178(2):291-6. PubMed ID: 6210214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between leukemogenicity and in vivo inducibility of normal differentiation in mouse myeloid leukemia cells.
    Honma Y; Kasukabe T; Hozumi M
    J Natl Cancer Inst; 1978 Sep; 61(3):837-41. PubMed ID: 278861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and characterization of a transplantable rat myelomonocytic leukemia.
    Moriuchi T; Oikawa T; Kodama T; Yamaguchi H; Kobayashi H
    Cancer Res; 1983 Nov; 43(11):5478-83. PubMed ID: 6577949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a macrophage chemokinetic factor in tumor cell culture media.
    Lane RD; Kaplan AM; Snodgrass MJ; Szakal AK
    J Reticuloendothel Soc; 1982 Feb; 31(2):171-84. PubMed ID: 7062320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chalone-like inhibition of Ehrlich ascites cell proliferation in vitro by an ultrafiltrate obtained from the ascitic fluid.
    Lehmann W; Graetz H; Schütt M; Langen P
    Acta Biol Med Ger; 1977; 36(7-8):K 43-52. PubMed ID: 148196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different colony stimulating activity by tumoral ascitic fluid and conditioned media.
    Garotta G; Burdick L; Porta C; Eridani S
    Exp Hematol; 1978 May; 6(5):505-12. PubMed ID: 306930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte colony-stimulating factor and differentiation-induction in myeloid leukemic cells.
    Nicola NA
    Int J Cell Cloning; 1987 Jan; 5(1):1-15. PubMed ID: 3031177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of differentiation of mouse myeloid leukemic cells and induction of interferon in the cells by double-stranded polyribonucleotides.
    Yamamoto Y; Tomida M; Hozumi M
    Cancer Res; 1979 Oct; 39(10):4170-4. PubMed ID: 289438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis by mouse peritoneal cells of G-CSF, the differentiation inducer for myeloid leukemia cells: stimulation by endotoxin, M-CSF and multi-CSF.
    Metcalf D; Nicola NA
    Leuk Res; 1985; 9(1):35-50. PubMed ID: 3887043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of differentiation of mouse myeloid leukemia cells by phenolic antioxidants and alpha-tocopherol.
    Takenaga K; Honma Y; Hozumi M
    Gan; 1981 Feb; 72(1):104-12. PubMed ID: 6944240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific binding of a factor inducing differentiation to mouse myeloid leukemic M1 cells.
    Yamamoto-Yamaguchi Y; Tomida M; Hozumi M
    Exp Cell Res; 1986 May; 164(1):97-102. PubMed ID: 3485533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of RNA and protein syntheses makes non-differentiating mouse myeloid leukemia cells sensitive to a factor(s) stimulating differentiation.
    Okabe J; Honma Y; Hozumi M
    Int J Cancer; 1977 Dec; 20(6):933-40. PubMed ID: 271144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that G-CSF is a fibroblast growth factor that induces granulocytes to increase phagocytosis and to present a mature morphology, and that macrophages secrete 45-kd molecules with these activities as well as with G-CSF-like activity.
    Mendoza JF; Cáceres JR; Santiago E; Mora LM; Sánchez L; Corona TM; Machuca C; Zambrano IR; Martínez RD; Weiss-Steider B
    Exp Hematol; 1990 Sep; 18(8):903-10. PubMed ID: 1696904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of a colony-stimulating factor following differentiation of leukemic myleoblasts to macrophages.
    Maeda M; Ichikawa Y
    J Cell Physiol; 1980 Mar; 102(3):323-31. PubMed ID: 6967070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of plasmacytoma cells on the production of granulocyte-macrophage colony-stimulating activity (GM-CSA) in the spleen of tumor-bearing mice.
    Merchav S; Apte RN; Tatarsky I; Ber R
    Exp Hematol; 1987 Oct; 15(9):995-1000. PubMed ID: 3498643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells.
    Zardi L; Cecconi C; Barbieri O; Carnemolla B; Picca M; Santi L
    Cancer Res; 1979 Sep; 39(9):3774-9. PubMed ID: 383288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ascites supernatant from Ehrlich carcinoma enhances the effect of differentiation inducers on mouse erythroleukemia cells].
    Hu JS; Huang J; Zhen YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Aug; 8(4):286-90. PubMed ID: 2953477
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of a cell surface glycoprotein (p180) related to cell-substratum adhesion during differentiation of mouse myeloid leukemia cells.
    Sugiyama K; Tomida M; Honma Y; Hozumi M
    Cancer Res; 1980 Sep; 40(9):3387-91. PubMed ID: 6253064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
    Luo JC; Toyoda M; Shibuya M
    Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.